Sarepta Therapeutics, Inc. (BVMF:S1RP34)
Brazil · Delayed Price · Currency is BRL 4.700
-0.040 (-0.84%)
At close: Nov 12, 2025
Sarepta Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -271.51 | 235.24 | -535.98 | -703.49 | -418.78 | -554.13 | Upgrade |
Depreciation & Amortization | 49.72 | 37.72 | 44.4 | 41.86 | 38.02 | 26.46 | Upgrade |
Other Amortization | - | - | - | - | - | 0.45 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -102 | - | -102 | -107.98 | Upgrade |
Loss (Gain) From Sale of Investments | 45.86 | - | 30.32 | 2.58 | 4.39 | - | Upgrade |
Stock-Based Compensation | 143.06 | 184.3 | 182.51 | 233.02 | 113.94 | 108.07 | Upgrade |
Other Operating Activities | 174.71 | 53.56 | 360.84 | 140.16 | 19.43 | 80.54 | Upgrade |
Change in Accounts Receivable | 38.79 | -201.66 | -185.7 | -61.64 | -51.65 | -10.46 | Upgrade |
Change in Inventory | -481.23 | -395.17 | -147.71 | -50.78 | -83.77 | -60.58 | Upgrade |
Change in Accounts Payable | -21.13 | 110.65 | -50.14 | 147.57 | 23.3 | 42 | Upgrade |
Change in Unearned Revenue | 33.45 | -32.16 | -86.83 | -89.24 | -89.24 | 749.43 | Upgrade |
Change in Other Net Operating Assets | 43.66 | -198.26 | -10.71 | 14.62 | 103.2 | -166.33 | Upgrade |
Operating Cash Flow | -244.64 | -205.79 | -500.99 | -325.35 | -443.17 | 107.47 | Upgrade |
Capital Expenditures | -136.46 | -136.96 | -76.11 | -30.82 | -38.49 | -82.2 | Upgrade |
Sale (Purchase) of Intangibles | -7.74 | -10 | 90.76 | -1.43 | 99.69 | 108.07 | Upgrade |
Investment in Securities | 881.75 | 902.52 | -180.46 | -1,015 | 434.21 | -144.09 | Upgrade |
Other Investing Activities | - | - | - | - | - | -3.5 | Upgrade |
Investing Cash Flow | 737.55 | 755.56 | -165.8 | -1,047 | 495.41 | -121.72 | Upgrade |
Long-Term Debt Issued | - | - | - | 1,127 | - | 291.15 | Upgrade |
Long-Term Debt Repaid | - | -0.07 | - | -823.23 | - | - | Upgrade |
Net Debt Issued (Repaid) | -127.52 | -0.07 | - | 304.17 | - | 291.15 | Upgrade |
Issuance of Common Stock | 42.11 | 79.53 | 51.25 | 30.04 | 569.33 | 396.01 | Upgrade |
Repurchase of Common Stock | -25.01 | - | - | - | -7.77 | -4.8 | Upgrade |
Other Financing Activities | 30.29 | 45.35 | 73.76 | -101.7 | - | -0.04 | Upgrade |
Financing Cash Flow | -80.15 | 124.81 | 125 | 232.51 | 561.57 | 682.32 | Upgrade |
Net Cash Flow | 412.77 | 674.58 | -541.79 | -1,140 | 613.81 | 668.07 | Upgrade |
Free Cash Flow | -381.1 | -342.74 | -577.1 | -356.17 | -481.66 | 25.26 | Upgrade |
Free Cash Flow Margin | -15.79% | -18.02% | -46.41% | -38.17% | -68.62% | 4.68% | Upgrade |
Free Cash Flow Per Share | -3.89 | -3.18 | -6.25 | -4.07 | -5.93 | 0.32 | Upgrade |
Cash Interest Paid | 14.65 | 15.86 | 15.92 | 44.42 | 55.95 | 34.42 | Upgrade |
Cash Income Tax Paid | 32.22 | 22.59 | 15.08 | 1.7 | 0.58 | 2.51 | Upgrade |
Levered Free Cash Flow | -82.47 | -445.48 | -330.11 | -54.65 | -8.7 | -280.36 | Upgrade |
Unlevered Free Cash Flow | -68.86 | -433.99 | -316.36 | -21.37 | 31.01 | -242.89 | Upgrade |
Change in Working Capital | -386.47 | -716.61 | -481.09 | -39.47 | -98.17 | 554.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.